Experimental Colitis in Rats With Portal Hypertension and Liver Disease

Within the colonic mucosa of rats with portal hypertension and liver cirrhosis, there is an increased generation of inflammatory mediators, such as leukotriene B4 and endothelin-1, and increased generation of nitric oxide. Nitric oxide overproduction may induce tissue injury. This study was undertaken to assess whether the colonic mucosa of rats with portal hypertension and liver disease have increased susceptibility to damage by noxious agents. In this study, acetic acid colitis was induced in rats with portal vein ligation and in control groups, and iodoacetamide colitis was induced in rats with partial portal vein ligation and cirrhosis due to bile duct ligation and in control groups. Rats with acetic acid colitis and those with iodoacetamide-induced colitis were studied 24 and 72 hours, respectively, after induction of colitis. Portal hypertension alone and portal hypertension with cirrhosis were present in the portal vein ligation and bile duct ligation models, respectively. In the rats with acetic acid, colitis lesion area, colonic mucosal myeloperoxidase activity, and prostaglandin E2 generation were not different between the portal vein ligation groups with and without colitis. Nitric oxide activity was higher only in the groups with colitis, irrespective of the presence of portal hypertension. In the group of rats with iodoacetamide colitis, colonic lesion area and colonic mucosal myeloperoxidase activity were similar in all groups with colitis. Colonic mucosal prostaglandin E2 generation was lower in the portal vein ligation and bile duct ligation rats with colitis compared with a control group. We concluded that rats with experimental portal hypertension do not have increased damage when induced by either acetic acid or iodoacetamide.

[1]  Z. Ackerman,et al.  Gastric and colonic inflammatory and vasoactive mediators in experimental portal hypertension. , 2008, Liver.

[2]  J. Wallace,et al.  Nitric oxide in mucosal defense: a little goes a long way. , 2000, Gastroenterology.

[3]  P. Kubes,et al.  Nitric oxide and intestinal inflammation. , 2000, The American journal of medicine.

[4]  J. Wallace,et al.  Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. , 1999, Gastroenterology.

[5]  J. Wallace,et al.  V. Therapeutic potential of nitric oxide donors and inhibitors. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[6]  R. Moreau,et al.  Vascular nitric oxide production during the development of two experimental models of portal hypertension. , 1999, Journal of hepatology.

[7]  R. Groszmann,et al.  NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[8]  M. Bertoni,et al.  Colonic disease in cirrhotic patients with portal hypertension: an endoscopic and clinical evaluation. , 1998, Journal of clinical gastroenterology.

[9]  K. Sugimachi,et al.  Overexpressed nitric oxide synthase in portal-hypertensive stomach of rat: a key to increased susceptibility to damage? , 1997, Gastroenterology.

[10]  W. Jiménez,et al.  Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. , 1996, Hepatology.

[11]  K. Morris,et al.  Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats , 1996, Hepatology.

[12]  P. Cahill,et al.  Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. , 1996, Journal of hepatology.

[13]  S. D. Lee,et al.  Colonic mucosal changes in patients with liver cirrhosis. , 1995, Gastrointestinal endoscopy.

[14]  P. Kubes,et al.  Neutrophil adhesion is impaired in rat model of cholestasis. , 1995, Gastroenterology.

[15]  D. Rachmilewitz,et al.  Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. , 1995, Gut.

[16]  D. Rachmilewitz,et al.  Sulfhydryl blocker-induced rat colonic inflammation is ameliorated by inhibition of nitric oxide synthase. , 1995, Gastroenterology.

[17]  J. Rodés,et al.  Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. , 1995, Gastroenterology.

[18]  J. Stamler,et al.  Peroxynitrite-induced rat colitis--a new model of colonic inflammation. , 1993, Gastroenterology.

[19]  E. Baldi,et al.  Impaired superoxide anion, platelet-activating factor, and leukotriene B4 synthesis by neutrophils in cirrhosis. , 1993, Gastroenterology.

[20]  E. Quigley,et al.  Bacterial translocation in the portal-hypertensive rat: studies in basal conditions and on exposure to hemorrhagic shock. , 1993, Gastroenterology.

[21]  E. Sikuler,et al.  Increased neutrophil function induced by bile duct ligation in a rat model , 1993, Hepatology.

[22]  C. Gostout,et al.  Portal hypertensive intestinal vasculopathy: a review of the clinical, endoscopic, and histopathologic features. , 1992, The American journal of gastroenterology.

[23]  R. Eliakim,et al.  Inflammatory mediators and the pathogenesis of inflammatory bowel disease. , 1992, The Italian journal of gastroenterology.

[24]  Tamaki Yamada,et al.  A comparative analysis of two models of colitis in rats. , 1992, Gastroenterology.

[25]  R. Eliakim,et al.  Colonic endothelin-1 immunoreactivity in active ulcerative colitis , 1992, The Lancet.

[26]  W. Sessa,et al.  High endothelin-1 immunoreactivity in Crohn's disease and ulcerative colitis , 1992, The Lancet.

[27]  R. Kozarek,et al.  Portal colopathy: prospective study of colonoscopy in patients with portal hypertension. , 1991, Gastroenterology.

[28]  D. V. van Thiel,et al.  Colonic disease in cirrhosis. An endoscopic evaluation in 412 patients. , 1990, Gastroenterology.

[29]  B. Rowlands,et al.  Inflammatory cell function in young rodents with experimental cholestasis: investigations of functional deficits, their etiology, and their reversibility. , 1989, Journal of pediatric surgery.

[30]  B. Rowlands,et al.  Impaired nonspecific cellular immunity in experimental cholestasis. , 1987, Annals of surgery.

[31]  D. Priebat,et al.  Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. , 1982, The Journal of investigative dermatology.

[32]  R. Colman,et al.  Experimental models of inflammatory bowel disease. , 2003, Archivum immunologiae et therapiae experimentalis.

[33]  S. Naveau,et al.  Portal hypertensive colopathy. A new entity. , 1991, Digestive diseases and sciences.

[34]  G. Castro,et al.  Relation of peroxidase activity in gut mucosa to inflammation. , 1978, The American journal of physiology.